| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.032 | 0.9 |